Percutaneous left atrial appendage closure: the CHAMPION-like vs. CLOSURE-like patient phenotype framework
Europace · 04.11.2026 · 28 (11)
DOI: 10.1093/europace/euag286 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Europace, online erschienen am 05.10.2026. Verfasst von Sergio Berti und 10 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione Toscana Gabriele Monasterio, Ospedale del Cuore 'G. Pasquinucci', Via Aurelia Sud, 54100 Massa, Italy. Hauptthemen laut MEDLINE: Left Atrial Appendage Closure, Atrial Fibrillation, Stroke, Atrial Appendage. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
The near-simultaneous publication of CHAMPION-AF and CLOSURE-AF produced apparently discordant evidence regarding percutaneous left atrial appendage closure (LAAC) for stroke prevention in atrial fibrillation. We aimed to reconcile these findings through a phenotype-based framework and identify the determinants of net clinical benefit. Methods and results This narrative review integrates randomized trials, registries, consensus documents, and guidelines, focusing on patient selection, procedural risk, post-implant antithrombotic therapy, endpoint construction, competing mortality, and time to benefit. CHAMPION-AF evaluated LAAC against direct oral anticoagulation in an elective, anticoagulation-eligible population with lower bleeding risk, demonstrating non-inferior thromboembolic protection and less non-procedural bleeding. Conversely, CLOSURE-AF enrolled an older, multimorbid population with substantial renal dysfunction, previous bleeding, and high competing mortality. Although implantation success and stroke rates were comparable between treatment groups, early procedural and antithrombotic-related bleeding, a composite endpoint incorporating procedural events, and limited survival reduced the opportunity for delayed benefit. The highly selective recruitment pathway further limits generalizability. These findings define a continuum from the ‘CHAMPION-like’ patient, with sufficient physiological reserve and life expectancy to realize long-term benefit, to the ‘CLOSURE-like’ patient, in whom frailty and competing risk may outweigh the advantage of appendage exclusion.
Conclusion
Left atrial appendage closure efficacy is not determined by device performance alone but by matching the intervention to patient phenotype and time horizon. Selection should integrate thromboembolic and bleeding risk, frailty, renal function, post-implant treatment tolerance, and expected survival. Future trials require transparent screening data, time-sensitive endpoints, landmark analyses, and competing-risk methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fondazione Toscana Gabriele Monasterio, Ospedale del Cuore 'G. Pasquinucci', Via Aurelia Sud, 54100 Massa, Italy.
- Interdisciplinary Center for Health Sciences, Scuola Superiore Sant'Anna, Piazza Martiri della Libertà, 33, 56127 Pisa, Italy.
- Institut Cardiovasculaire Paris Sud (ICPS), Hôpital Privé Jacques Cartier, Ramsay Santé, Massy, France.
- Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
- Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, United Kingdom.
- Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
ORCID-Profile: Sergio Berti, Philippe Garot, Giancarlo Trimarchi, Jens Erik Nielsen-Kudsk, Gregory Y H Lip, Carsten Skurk, Valeria Caso, Lucas V A Boersma, Domenico G Della Rocca, Giuseppe Boriani, Alan John Camm
Zitieren
APA
Berti, S., Garot, P., Trimarchi, G., Nielsen-Kudsk, J. E., Lip, G. Y. H., Skurk, C., Caso, V., Boersma, L. V. A., Della Rocca, D. G., Boriani, G., & Camm, A. J. (2026). Percutaneous left atrial appendage closure: the CHAMPION-like vs. CLOSURE-like patient phenotype framework. Europace, 28(11). https://doi.org/10.1093/europace/euag286
Vancouver
Berti S, Garot P, Trimarchi G, Nielsen-Kudsk JE, Lip GYH, Skurk C, et al. Percutaneous left atrial appendage closure: the CHAMPION-like vs. CLOSURE-like patient phenotype framework. Europace. 2026;28(11). doi:10.1093/europace/euag286
BibTeX
@article{Berti2026,
author = {Berti, Sergio and Garot, Philippe and Trimarchi, Giancarlo and Nielsen-Kudsk, Jens Erik and Lip, Gregory Y H and Skurk, Carsten and Caso, Valeria and Boersma, Lucas V A and Della Rocca, Domenico G and Boriani, Giuseppe and Camm, Alan John},
title = {Percutaneous left atrial appendage closure: the CHAMPION-like vs. CLOSURE-like patient phenotype framework},
journal = {Europace},
year = {2026},
volume = {28},
number = {11},
doi = {10.1093/europace/euag286}
}
EUVIMED